We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+7.53%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$20B
AUM Growth
-$1.4B
Cap. Flow
-$2.71B
Cap. Flow %
-13.53%
Top 10 Hldgs %
37.39%
Holding
342
New
43
Increased
66
Reduced
43
Closed
42

Sector Composition

Rank Sector Weight
1 Healthcare 31.82%
2 Industrials 13.15%
3 Financials 12.22%
4 Communication Services 10.32%
5 Technology 10.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFX icon
26
Equifax
EFX
$21.4B
$294M 1.47%
1,005,183
+113,600
+13% +$31.6M
CRM icon
27
Salesforce
CRM
$158B
$283M 1.41%
1,113,638
-464,277
-29% -$130M
SJR
28
DELISTED
Shaw Communications Inc.
SJR
$227M 1.13%
7,467,800
+1,197,800
+19% +$35M
ABBV icon
29
AbbVie
ABBV
$435B
$218M 1.09%
1,608,451
+1,126,603
+234% +$133M
ADBE icon
30
Adobe
ADBE
$105B
$213M 1.06%
+376,000
New +$235M
CHTR icon
31
Charter Communications
CHTR
$18.2B
$206M 1.03%
315,701
-65,300
-17% -$44.5M
ALNY icon
32
Alnylam Pharmaceuticals
ALNY
$29.3B
$202M 1.01%
1,190,028
+375,727
+46% +$69.8M
NUAN
33
DELISTED
Nuance Communications, Inc.
NUAN
$190M 0.95%
3,430,681
-5,929,319
-63% -$327M
BEAM icon
34
Beam Therapeutics
BEAM
$2.84B
$181M 0.9%
2,265,045
+547,455
+32% +$46.9M
EXEL icon
35
Exelixis
EXEL
$13.4B
$162M 0.81%
8,859,157
-800,555
-8% -$15.3M
AVTR icon
36
Avantor
AVTR
$9.19B
$154M 0.77%
3,642,858
+377,707
+12% +$14.9M
HZNP
37
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$150M 0.75%
1,396,217
+224,043
+19% +$24.4M
NTRA icon
38
Natera
NTRA
$46.4B
$138M 0.69%
1,472,715
+172,581
+13% +$17.9M
CVS icon
39
CVS Health
CVS
$122B
$132M 0.66%
1,281,456
+1,047,456
+448% +$96.8M
LH icon
40
Labcorp
LH
$25.9B
$130M 0.65%
482,093
+67,859
+16% +$16.8M
ENTA icon
41
Enanta Pharmaceuticals
ENTA
$400M
$118M 0.59%
1,573,829
-421,171
-21% -$33.1M
YMM icon
42
Full Truck Alliance
YMM
$9.99B
$117M 0.59%
14,007,743
+13,192,743
+1,619% +$174M
IOVA icon
43
Iovance Biotherapeutics
IOVA
$2.87B
$116M 0.58%
6,061,973
+721,979
+14% +$15.9M
COHR
44
DELISTED
Coherent Inc
COHR
$115M 0.57%
430,000
+10,000
+2% +$2.58M
AZN icon
45
AstraZeneca
AZN
$250B
$111M 0.55%
953,078
+786,078
+471% +$92.5M
LU icon
46
Lufax Holding
LU
$1.3B
$107M 0.53%
4,754,850
+1,165,625
+32% +$30.5M
CYTK icon
47
Cytokinetics
CYTK
$10.4B
$98.9M 0.49%
2,170,342
-562,433
-21% -$21.7M
CTLT
48
DELISTED
CATALENT, INC.
CTLT
$97.8M 0.49%
763,561
-166,638
-18% -$21.4M
BPMC
49
DELISTED
Blueprint Medicines
BPMC
$86.9M 0.43%
811,747
-132,656
-14% -$13.9M
PCG icon
50
PG&E
PCG
$38.5B
$76.5M 0.38%
6,305,142
-986,900
-14% -$11.6M

Similar funds

Farallon Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Farallon Capital Management held 342 positions worth $20B, down 6.6% from $21.4B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Farallon Capital Management withdrew a net $2.71B in Q4 2021, closing 42 positions and reducing 43 holdings. Its most notable exit was T-Mobile US, an estimated $588M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Industrials and Financials.

Against the trend, Farallon Capital Management opened a new position in Adobe worth $213M.

  • Farallon Capital Management's largest Q4 2021 buy was Adobe: 376,000 shares worth $213M.
  • Farallon Capital Management added most to Howmet Aerospace in Q4 2021, an estimated $189M increase.
  • Farallon Capital Management's biggest Q4 2021 reduction was Nuance Communications, Inc., cutting an estimated $327M.
  • Farallon Capital Management fully exited T-Mobile US in Q4 2021, selling an estimated $588M.
  • Farallon Capital Management's ten largest holdings make up 37% of its $20B portfolio in Q4 2021.
  • Farallon Capital Management opened 43 new positions and closed 42 in Q4 2021.
  • Farallon Capital Management's portfolio value fell 6.6% quarter-over-quarter to $20B.

Based on Farallon Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.